WHO ICTRP trial
Treatment with olaparib in patients with breast cancer
EUCTR2017-001054-34-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-001054-34-GB |
|---|---|
| Public title | Treatment with olaparib in patients with breast cancer |
| Scientific title | LUCY - Lynparza Breast Cancer Real World Utility, Clinical Effectiveness and Safety Study A Phase IIIb, Single-arm, Open-label Multicentre Study of Olaparib Monotherapy in the Treatment of HER2-ve Metastatic Breast Cancer Patients with Germline or Somatic BRCA1/2 Mutations - LUCY |
| Primary sponsor | AstraZeneca AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;Taiwan;Spain;Turkey;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Poland;Bulgaria;Germany;China;Japan;Korea, Republic of |
| Conditions | Metastatic Breast Cancer MedDRA version: 20.0 Level: PT Classification code 10006187 Term: Breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C]… |
| Interventions | Product Name: olaparib 100 mg Product Code: AZD2281 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: olaparib CAS Number: 763113-22-0 Current Sponsor code: AZD2281 Concentration unit: mg milligram(s) Concentration type: equal… |
| Registration date | Sep 28, 2017 |
| Target size | 270 |
| Secondary IDs | D0816C00018;NCT03286842 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: